Results
|
|
41.
|
|
|
|
42.
|
Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. [electronic resource] by
- Eaton, Anne
- Iasonos, Alexia
- Gounder, Mrinal M
- Pamer, Erika G
- Drilon, Alexander
- Vulih, Diana
- Smith, Gary L
- Ivy, S Percy
- Spriggs, David R
- Hyman, David M
Producer: 20161025
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|
|
|
43.
|
Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program. [electronic resource] by
- Drilon, Alexander
- Eaton, Anne A
- Schindler, Katja
- Gounder, Mrinal M
- Spriggs, David R
- Harris, Pamela
- Ivy, S Percy
- Iasonos, Alexia
- Lacouture, Mario E
- Hyman, David M
Producer: 20160822
In:
Cancer vol. 122
Availability: No items available.
|
|
|
44.
|
|
|
|
45.
|
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. [electronic resource] by
- Hechtman, Jaclyn F
- Benayed, Ryma
- Hyman, David M
- Drilon, Alexander
- Zehir, Ahmet
- Frosina, Denise
- Arcila, Maria E
- Dogan, Snjezana
- Klimstra, David S
- Ladanyi, Marc
- Jungbluth, Achim A
Producer: 20171023
In:
The American journal of surgical pathology vol. 41
Availability: No items available.
|
|
|
46.
|
Response to Selective RET Inhibition With LOXO-292 in a Patient With [electronic resource] by
- Guo, Robin
- Schreyer, Mark
- Chang, Jason C
- Rothenberg, S Michael
- Henry, Dahlia
- Cotzia, Paolo
- Kris, Mark G
- Rekhtman, Natasha
- Young, Robert J
- Hyman, David M
- Drilon, Alexander
Publication details: JCO precision oncology 2019
In:
JCO precision oncology vol. 3
Availability: No items available.
|
|
|
47.
|
Single-agent dabrafenib for [electronic resource] by
- Bhatia, Ankush
- Ulaner, Gary
- Rampal, Raajit
- Hyman, David M
- Abdel-Wahab, Omar
- Durham, Benjamin H
- Dogan, Ahmet
- Ozkaya, Neval
- Lacouture, Mario E
- Hajdenberg, Julio
- Ganzel, Chezi
- Diamond, Eli L
Producer: 20190715
In:
Haematologica vol. 103
Availability: No items available.
|
|
|
48.
|
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. [electronic resource] by
- Bendell, Johanna C
- Varghese, Anna M
- Hyman, David M
- Bauer, Todd M
- Pant, Shubham
- Callies, Sophie
- Lin, Ji
- Martinez, Ricardo
- Wickremsinhe, Enaksha
- Fink, Aaron
- Wacheck, Volker
- Moore, Kathleen N
Producer: 20191220
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
|
49.
|
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion. [electronic resource] by
- Rao, Thapi D
- Tian, Huasong
- Ma, Xun
- Yan, Xiujun
- Thapi, Sahityasri
- Schultz, Nikolaus
- Rosales, Nestor
- Monette, Sebastien
- Wang, Amy
- Hyman, David M
- Levine, Douglas A
- Solit, David
- Spriggs, David R
Producer: 20160201
In:
PloS one vol. 10
Availability: No items available.
|
|
|
50.
|
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors. [electronic resource] by
- Hyman, David M
- Rizvi, Naiyer
- Natale, Ronald
- Armstrong, Deborah K
- Birrer, Michael
- Recht, Lawrence
- Dotan, Efrat
- Makker, Vicky
- Kaley, Thomas
- Kuruvilla, Denison
- Gribbin, Matthew
- McDevitt, Jennifer
- Lai, Dominic W
- Dar, Mohammed
Producer: 20191119
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
|
51.
|
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF. [electronic resource] by
- Hechtman, Jaclyn F
- Zehir, Ahmet
- Yaeger, Rona
- Wang, Lu
- Middha, Sumit
- Zheng, Tao
- Hyman, David M
- Solit, David
- Arcila, Maria E
- Borsu, Laetitia
- Shia, Jinru
- Vakiani, Efsevia
- Saltz, Leonard
- Ladanyi, Marc
Producer: 20161213
In:
Molecular cancer research : MCR vol. 14
Availability: No items available.
|
|
|
52.
|
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family. [electronic resource] by
- Yang, Ciyu
- Arnold, Angela G
- Trottier, Magan
- Sonoda, Yukio
- Abu-Rustum, Nadeem R
- Zivanovic, Oliver
- Robson, Mark E
- Stadler, Zsofia K
- Walsh, Michael F
- Hyman, David M
- Offit, Kenneth
- Zhang, Liying
Producer: 20171207
In:
Breast cancer research and treatment vol. 160
Availability: No items available.
|
|
|
53.
|
Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma. [electronic resource] by
- Hyman, David M
- Long, Kara C
- Tanner, Edward J
- Grisham, Rachel N
- Arnold, Angela G
- Bhatia, Jasmine
- Phillips, Mary F
- Spriggs, David R
- Soslow, Robert A
- Kauff, Noah D
- Levine, Douglas A
Producer: 20121109
In:
Gynecologic oncology vol. 126
Availability: No items available.
|
|
|
54.
|
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. [electronic resource] by
- Grisham, Rachel N
- Iyer, Gopa
- Garg, Karuna
- Delair, Deborah
- Hyman, David M
- Zhou, Qin
- Iasonos, Alexia
- Berger, Michael F
- Dao, Fanny
- Spriggs, David R
- Levine, Douglas A
- Aghajanian, Carol
- Solit, David B
Producer: 20130321
In:
Cancer vol. 119
Availability: No items available.
|
|
|
55.
|
A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D. [electronic resource] by
- Hyman, David M
- Sill, Michael W
- Lankes, Heather A
- Piekarz, Richard
- Shahin, Mark S
- Ridgway, Mildred R
- Backes, Floor
- Tenney, Meaghen E
- Mathews, Cara A
- Hoffman, James S
- Aghajanian, Carol
- Hensley, Martee L
Producer: 20170530
In:
Gynecologic oncology vol. 144
Availability: No items available.
|
|
|
56.
|
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT. [electronic resource] by
- Ulaner, Gary A
- Hyman, David M
- Ross, Dara S
- Corben, Adriana
- Chandarlapaty, Sarat
- Goldfarb, Shari
- McArthur, Heather
- Erinjeri, Joseph P
- Solomon, Stephen B
- Kolb, Hartmuth
- Lyashchenko, Serge K
- Lewis, Jason S
- Carrasquillo, Jorge A
Producer: 20170509
In:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 57
Availability: No items available.
|
|
|
57.
|
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. [electronic resource] by
- Solomon, James P
- Linkov, Irina
- Rosado, Andrea
- Mullaney, Kerry
- Rosen, Ezra Y
- Frosina, Denise
- Jungbluth, Achim A
- Zehir, Ahmet
- Benayed, Ryma
- Drilon, Alexander
- Hyman, David M
- Ladanyi, Marc
- Sireci, Anthony N
- Hechtman, Jaclyn F
Producer: 20201207
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 33
Availability: No items available.
|
|
|
58.
|
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib. [electronic resource] by
- Ulaner, Gary A
- Saura, Cristina
- Piha-Paul, Sarina A
- Mayer, Ingrid
- Quinn, David
- Jhaveri, Komal
- Stone, Ben
- Shahin, Seta
- Mann, Grace
- Dujka, Melanie
- Bryce, Richard
- Meric-Bernstam, Funda
- Solit, David B
- Hyman, David M
Producer: 20201026
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
|
59.
|
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer. [electronic resource] by
- Hyman, David M
- Zhou, Qin
- Iasonos, Alexia
- Grisham, Rachel N
- Arnold, Angela G
- Phillips, Mary F
- Bhatia, Jasmine
- Levine, Douglas A
- Aghajanian, Carol
- Offit, Kenneth
- Barakat, Richard R
- Spriggs, David R
- Kauff, Noah D
Producer: 20120928
In:
Cancer vol. 118
Availability: No items available.
|
|
|
60.
|
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay. [electronic resource] by
- Ross, Dara S
- Zehir, Ahmet
- Cheng, Donavan T
- Benayed, Ryma
- Nafa, Khedoudja
- Hechtman, Jaclyn F
- Janjigian, Yelena Y
- Weigelt, Britta
- Razavi, Pedram
- Hyman, David M
- Baselga, José
- Berger, Michael F
- Ladanyi, Marc
- Arcila, Maria E
Producer: 20170615
In:
The Journal of molecular diagnostics : JMD vol. 19
Availability: No items available.
|